- Rank in Search Criteria: 3421
World Rank (Jan-05-2024): 19,312
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 19661
Market Cap (Jul-30-2023): 0.15 Billion USD
World Rank (Jan-2022): 20,822
Market Cap (Jan-2022): 0.14 Billion USD
- Rank in Search Criteria: 3422
World Rank (Jan-05-2024): 19,314
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 22655
Market Cap (Jul-30-2023): 0.08 Billion USD
World Rank (Jan-2022): 18,632
Market Cap (Jan-2022): 0.22 Billion USD
- Rank in Search Criteria: 3423
World Rank (Jan-05-2024): 19,316
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 19253
Market Cap (Jul-30-2023): 0.16 Billion USD
- Rank in Search Criteria: 3424
World Rank (Jan-05-2024): 19,320
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 19768
Market Cap (Jul-30-2023): 0.15 Billion USD
World Rank (Jan-2022): 20,870
Market Cap (Jan-2022): 0.14 Billion USD
- Rank in Search Criteria: 3425
World Rank (Jan-05-2024): 19,347
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 19535
World Rank (Jan-2022): 19,535
Market Cap (Jan-2022): 0.18 Billion USDHeadquarters Country: Spain
- Rank in Search Criteria: 3426
World Rank (Jan-05-2024): 19,356
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 19387
Market Cap (Jul-30-2023): 0.16 Billion USD
World Rank (Jan-2022): 16,758
Market Cap (Jan-2022): 0.30 Billion USDCompany Profile: Trifast is a international specialist in the engineering, manufacturing and distribution of high quality industrial fastenings to major global assembly industries. It has a global logistics capability from 34 business locations within the UK, Asia, Europe and the USA. The headquarters is in UK.
Facts About Company: Trifast company annual revenue was 244 million GBP and annual net loss was -2 million GBP as on Mar-2023.
- Rank in Search Criteria: 3427
World Rank (Jan-05-2024): 19,359
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 21504
Market Cap (Jul-30-2023): 0.10 Billion USD
World Rank (Jan-2022): 7,370
Market Cap (Jan-2022): 1.52 Billion USDAnnual Revenue in USD: 0 Million USD
Annual Net Income in USD: -246 Million USD
Annual Results for Period ending: Dec-2020 ending yearEmployee Count: 116
Employee Count as of Date: As on 2020
Company Profile: ADC Therapeutics is a Clinical Stage Oncology Biotechnology company, development and commercialization of next generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology. The headquarters is in Switzerland.
Facts About Company: ADC Therapeutics company annual revenue was 209 million USD and annual net loss was -155 million USD as on Dec-2022.
- Rank in Search Criteria: 3428
World Rank (Jan-05-2024): 19,369
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 19343
Market Cap (Jul-30-2023): 0.16 Billion USD
- Rank in Search Criteria: 3429
World Rank (Jan-05-2024): 19,370
Market Cap (Jan-05-2024): 0.15 Billion USD
World Rank (Jul-30-2023): 20833
Market Cap (Jul-30-2023): 0.17 Billion USD
World Rank (Jan-2022): 20,193
Market Cap (Jan-2022): 0.16 Billion USDHeadquarters Country: Italy
- Rank in Search Criteria: 3430
World Rank (Jan-05-2024): 19,376
World Rank (Jul-30-2023): 19376
World Rank (Jan-2022): 19,376